Quebec – Montreal – Mount Royal
Corporation
www.biophagepharma.net
Quebec
Montreal
Mount Royal
Corporation
active
Biophage Inc. is a privately held Montreal based
biopharmaceutical company founded in 1995 that discovers and
develops proprietary therapeutic products for the treatment of
inflammation in humans and bacterial infections in livestock and
humans. Biophage technology platforms are based on the unique
properties of phages and antibodies
Biophage operates two divisions: (1) The R - D division and (2) The Contract Research Organization (CRO) division.
Biophage R - D division develops the Company€™s compounds with the objective of taking them to the market place or licensing them to Pharmaceutical companies once clear proof of concept has been established.
Biophage CRO division supports biotech and pharma companies in their early drug development by providing In vitro and In vivo development services in the fields of immunology, infectiology and oncology. Biophage provides assistance and support in developing customized screens and experimental models tailored to meet its client€™s specialized analytical requirements. The identity of clients and test results are handled under strict confidentiality. Our technical staff has extensive training and experience in: - Drug discovery and early stage drug development;
- Molecular Biology services including mRNA protection assay, RT-PCR, 2-Hybrid system,
- Custom antibody production, purification and antigenic prediction;
- Immunoassay development (Elisa, RIA, etc);
- Immunology and Immunotoxicology including 3-color Flow Cytometry, Cytokines, Effector cells evaluation
- Cell culture testing (mycoplasma and sterility testing);
- Phage display technologies and phage therapeutics
- Immune Modulators and Anti-infectives activity testing
- Development of mammalian and bacterial vectors
Efficacy tests including: (i) immunology and immunotoxicology;
(ii) in vitro and in vivo anti-tumor profiling using our panel of over 130 human and rodent cell lines;
(iii) complete and integrated services of necropsy and histopathology;
(iv) microbiological testing (bacteria, virus and fungi); and
(v) pilot toxicological studies in rodents.
Biophage Inc. senior management team has over 100 years of combined experience in business and technology development in health care and biotechnology industries. Biophage is led by Rosemonde Mandeville, M.D., Ph.D., (President, CEO - CSO).
Country of Ownership: Canada
Year Established: 1995
Exporting: Yes
Quality Certification: ISO 9001
Primary Industry (NAICS): 541710 - Research and Development in the Physical, Engineering and Life Sciences
Primary Business Activity: Manufacturer / Processor / Producer
Total Sales ($CDN): $500,000 to $999,999
Export Sales ($CDN): $100,000 to $199,999
Number of Employees: 21
Services:
Custom research services, Biotechnology
Technology:
Lisensed to exploit new, innovative and patented platform
technologies in the health industry with specific focus on
cancer, infection/inflammation, and immune modulation. Using our
Ligand Discovery Technology (LTD), Biophage designs and produces
thousands of unique new compunds, reducing the cost and speeding
the process of drug discovery.
Bentob Myer
Chin Pearl
Dubois Luc
Farah Elie
Mandeville Rosemonde
No associations
LandOfFree
Biophage Pharma Inc. does not yet have a rating. At this time, there are no reviews or comments for this company.
If you have personal experience with Biophage Pharma Inc., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biophage Pharma Inc. will most certainly appreciate the feedback.
Profile ID: LFCA-COD-O-3234